Cepheid Announces FDA Approval of Xpert Hemorrhagic Fever Panel
Photo: TokenPost
Cepheid announced Tuesday, Nov. 3, that the U.S. Food and Drug Administration (FDA) approved its Xpert Hemorrhagic Fever Panel. The product is a PCR test designed to detect multiple hemorrhagic fever viruses from one sample. Riza Dagoc reports on regulation, investing and the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
